Disease
84 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
This is a completed Phase 3 trial registration with no results posted; the registry record describes design and rationale only, precluding any evidence assessment of efficacy.
SEP 9, 2026 · INTERVENTIONAL STUDY
ClinicalTrials.gov
This is a completed trial registry record with no reported results; the study enrolled 673 participants in a randomized sham-controlled design, but outcomes have not yet been posted to the registry.
SEP 9, 2026 · PHASE 2 TRIAL
ClinicalTrials.gov
This is a Phase 2 trial registration with no posted results; it describes planned enrollment and outcomes but reports no efficacy or safety data.
SEP 9, 2026 · PHASE EARLY PHASE 1 TRIAL
ClinicalTrials.gov
Early-phase uncontrolled trial (Phase 1) examining dietary supplements in Alzheimer's disease with surrogate endpoints (brain glucose uptake, inflammation) and cognition measures; no results yet reported in this registry record.
Recruitment-completed interventional trial with behavioural diet interventions in Alzheimer's disease, but no results are reported in this registry record, preventing assessment of efficacy or safety.
SEP 8, 2026 · PHASE 1 TRIAL
ClinicalTrials.gov
This is an active interventional Phase 1 registry record with no published results; it describes a planned head-to-head harmonization study of tau PET tracers in Alzheimer's disease.
This is an active observational registry study with no posted results; it describes planned enrollment and specimen collection infrastructure rather than clinical outcomes or evidence.
This is a Phase 2 platform trial registration with no results reported; it describes a planned interventional study in early-stage disease with a surrogate endpoint (tau PET), appropriate for preliminary classification.